Medical News

RSS

TAFP and RemitDATA team up to improve revenue and reimbursement trends

RemitDATA, Inc., a leading provider of web-based productivity tools and benchmarking to the outpatient healthcare market, today announced that Texas Academy of Family Physicians (TAFP), the largest medical specialty organization, serving over 5,500 family physicians in Texas, has joined forces with RemitDATA to aggregate members' reimbursement data and provide real-time payer benchmarking to help TAFP identify problematic payers and troubling reimbursement trends before they turn into cash-flow pitfalls.

8 Dec 2009

Muscle Flex returns to 'Current Information' status with PinkSheets.com

Muscle Flex Inc. (www.MuscleFlex.com) announced today that it has returned to 'Current Information' status with PinkSheets.com after filing its required financial information.

8 Dec 2009

Tranzyme Pharma and Bristol-Myers Squibb sign collaboration agreement

Tranzyme Pharma today announced that it has entered into a strategic collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds directed against targets of interest to Bristol-Myers Squibb.

8 Dec 2009

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

8 Dec 2009

VisionShare to enable connectivity to the NHIN and HIEs from its secure exchange platform

VisionShare, one of the nation’s largest and most secure health information exchanges for administrative transactions, today announced plans to expand support for the exchange of clinical transactions on its platform and making connectivity to the Nationwide Health Information Network (NHIN) and state and community-based Health Information Exchanges (HIEs) available to its customers.

8 Dec 2009

Catholics for Choice's statement on restriction of abortion coverage

"Today, Senator Ben Nelson (D-Nebraska) put the policy priorities of the U.S. Catholic bishops before the needs of women nationwide. Originally, Senator Nelson maintained that the abortion language in the healthcare bill was not a make-or-break factor in his vote.

8 Dec 2009

West Nile Virus can become more widespread in Europe than previously thought, says new report

Potentially fatal mosquito-borne West Nile fever (WNF) can become much more widespread in Europe than previously thought, say scientists in a new report just out in the journal BMC Evolutionary Biology(1).

8 Dec 2009

Opportunity for wireless technologies in Western Europe's e-healthcare market

Healthcare in Europe is facing major challenges in both structural reform and unavailability of resources as the region's working population is far lower in comparison to those of 'non-working' age. This calls for the introduction of new schemes in healthcare that would enable Europe to deal with issues pertaining to the growing ageing population.

8 Dec 2009

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.

8 Dec 2009

CML patients on nilotinib or dasatinib drug achieve better response than imatinib drug

Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.

8 Dec 2009

EPO grants patent for AbSorber's transplantation cross match-test

LinkMed’s subsidiary AbSorber has received patent protection for its transplantation cross match-test XM-ONE® in the European countries. The patent was previously approved in New Zealand which was the first country to approve a patent for AbSorbers product. The European countries are highly prioritized markets for AbSorber and the patent approval is an important milestone in Absorbers intellectual property strategy.

8 Dec 2009

Climate change may affect mental health, but more research is needed

Among the many topics to be discussed at the United Nations Climate Change Conference in Copenhagen this month, one that is unlikely to feature is that of increasing concern about the effects on climate change on people with a history of mental health, and the potential for an increase in the overall burden of mental disorder worldwide.

8 Dec 2009

Beryl launches H1N1 Risk Assessment service to provide useful information about H1N1 virus

The Beryl Companies, the nation’s leading provider of outsourced call center services for the healthcare industry, has launched a new service that will enhance hospitals’ abilities to provide useful information to consumers who have questions and concerns about the H1N1 virus.

8 Dec 2009

Results of two new studies support the use of intravenous Vimpat for patients in clinical settings

Results of two new studies support the use of the intravenous formulation of the antiepileptic drug (AED) Vimpat® for patients requiring add-on therapy in clinical settings where oral AED therapy is temporarily not feasible.

8 Dec 2009

Positive data from Onconova Therapeutics' ON 01910.Na trial for advanced MDS

Onconova Therapeutics, Inc. today announced promising results from two clinical trials in patients with advanced Myelodysplastic Syndrome (MDS) treated with ON 01910.Na. These trials are being conducted at the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, MD, and St. Vincent’s Comprehensive Cancer Center in New York.

8 Dec 2009

CeNeRx BioPharma's TriRima reversibly inhibits MAO-A, confirms PET imaging study

CeNeRx BioPharma, Inc., a clinical stage company developing innovative treatments for diseases of the central nervous system, today announced that a newly published PET imaging study in human subjects confirms that CeNeRx's novel compound TriRima(TM) reversibly inhibits MAO-A (monoamine oxidase A), an enzyme in the brain that plays a key role in the regulation of mood.

8 Dec 2009

Cedars-Sinai Regenerative Medicine Institute supplies stem cells to aid Huntington's disease research

The Cedars-Sinai Regenerative Medicine Institute is to provide stem cells to a five-member National Institutes of Health consortium of researchers for development of potential therapies to treat Huntington's disease.

8 Dec 2009

Positive data from ARIAD Pharmaceuticals' ongoing AP24534 study in advanced hematological cancer patients

ARIAD Pharmaceuticals, Inc. today announced positive clinical data from an ongoing Phase 1 study of its investigational, pan-BCR-ABL inhibitor, AP24534, in patients with advanced hematological cancers.

8 Dec 2009

Discovery may lead to new treatments for late-stage breast cancer

Researchers from the Indiana University School of Medicine and colleagues at the University of Texas Southwestern and Case Western University have determined how the protein Mdm2, which is elevated in late-stage cancers, disables genes that suppress the growth of tumors. The finding may lead to the development of new drugs for late stage breast cancer and other difficult to treat malignancies.

8 Dec 2009

SOLESTA pivotal study meets primary endpoints for fecal incontinence treatment

Q-Med AB and Oceana Therapeutics, Inc. today announced that the SOLESTA pivotal study succeeded in meeting both primary endpoints for the treatment of fecal incontinence.

8 Dec 2009

Medical News

TAFP and RemitDATA team up to improve revenue and reimbursement trends

Muscle Flex returns to 'Current Information' status with PinkSheets.com

Tranzyme Pharma and Bristol-Myers Squibb sign collaboration agreement

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

VisionShare to enable connectivity to the NHIN and HIEs from its secure exchange platform

Catholics for Choice's statement on restriction of abortion coverage

West Nile Virus can become more widespread in Europe than previously thought, says new report

Opportunity for wireless technologies in Western Europe's e-healthcare market

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

CML patients on nilotinib or dasatinib drug achieve better response than imatinib drug

EPO grants patent for AbSorber's transplantation cross match-test

Climate change may affect mental health, but more research is needed

Beryl launches H1N1 Risk Assessment service to provide useful information about H1N1 virus

Results of two new studies support the use of intravenous Vimpat for patients in clinical settings

Positive data from Onconova Therapeutics' ON 01910.Na trial for advanced MDS

CeNeRx BioPharma's TriRima reversibly inhibits MAO-A, confirms PET imaging study

Cedars-Sinai Regenerative Medicine Institute supplies stem cells to aid Huntington's disease research

Positive data from ARIAD Pharmaceuticals' ongoing AP24534 study in advanced hematological cancer patients

Discovery may lead to new treatments for late-stage breast cancer

SOLESTA pivotal study meets primary endpoints for fecal incontinence treatment

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News